Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Withdrawn 3Unknown 2Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Pathologic Processes 1Neoplastic Processes 1Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Electrochemotherapy × Clear all
NCT03040180 2019-01-25

nECT

Zealand University Hospital

Phase 2 Unknown
40 enrolled
Gastrointestinal

Neoplasms, Neoplastic Processes, Pathologic Processes, Rectal Neoplasms, Colorectal Neoplasms

NCT02549742 2017-01-18

Electrochemotherapy on Head and Neck Cancer

Rigshospitalet, Denmark

Phase 2 Unknown
25 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡